July 2008 Volume 4 Number 7
Visit Nature Clinical Practice Rheumatology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0pMu0Ef
"Officially endorsed by the Asia Pacific League of Associations for
Rheumatology"
=====================================================================
Web Focus and Special Feature on Dendritic Cells brought to you by
Immunology & Cell Biology
Featuring a collection of research and review articles on the latest
understanding of DC heterogeneity, this web focus also dives into the
realm of T cell responses and functional diversity. The accompanying
two-part special feature highlights the gaps in the understanding and
potential this holds for the future.
Access the Web Focus and Special Feature on Dendritic Cells to view
select articles FREE of charge!
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhI0Ed
=====================================================================
----------------------
EDITORIAL
----------------------
The future of specialty care in the US
Richard A Cooper
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhJ0Ee
----------------------
RESEARCH HIGHLIGHTS
----------------------
Combined MRI and SPECT assessment could aid diagnosis of NPSLE
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhK0Ef
Efficacy and safety of anti-TNF therapy for ankylosing spondylitis:
long-term results
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhL0Eg
Intravenous ibandronate is an effective and well-tolerated treatment
for osteoporosis
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhM0Eh
Possible role for complement inhibition in amelioration of arthritis
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhN0Ei
Novel CCL2 inhibitor alleviates established rat adjuvant-induced arthritis
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhO0Ej
MRI is more sensitive than radiography for the detection of RA wrist
bone erosions
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhP0Ek
In Briefs
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhQ0El
----------------------
PRACTICE POINTS
----------------------
Is computer-assisted management necessary for patients with early
rheumatoid arthritis?
Daniel Aletaha and Josef Smolen
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhR0Em
Balancing efficacy and cancer risk of cyclophosphamide for patients with
Wegener's granulomatosis
Eamonn S Molloy and Carol A Langford
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhS0En
Oral versus parenteral administration of methotrexate for the treatment
of active RA
Derrick J Todd and Michael E Weinblatt
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhT0Eo
Does early sulfasalazine treatment provide long-term benefits to patients
with juvenile idiopathic arthritis?
Tracy V Ting and Daniel J Lovell
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhU0Ep
What is the optimal treatment for patients with RA who fail to respond
to monotherapy with methotrexate?
Boulos Haraoui
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhV0Eq
----------------------
CLINICAL ADVANCES
----------------------
Are cannabinoids a new treatment option for pain in patients with
fibromyalgia?
Roland Staud and Eubee B Koo
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhW0Er
Is mizoribine a new therapeutic agent for Sjogren's syndrome?
Haralampos M Moutsopoulos and George E Fragoulis
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhX0Es
----------------------
VIEWPOINTS
----------------------
Type 17 T-helper cells might be a promising therapeutic target for
systemic lupus erythematosus
Hai Feng Pan, Dong Qing Ye and Xiang Pei Li
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhY0Et
Why do we need noncommercial, investigator-initiated clinical trials?
Alan Tyndall
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0ByhZ0Eu
----------------------
REVIEWS
----------------------
Ethical issues in rheumatology clinical trials
Jeremy Sugarman and Clifton O Bingham III
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byha0E2
Drug Insight: anti-tumor necrosis factor therapies for the vasculitic
diseases
Carol A Langford
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhb0E3
Technology Insight: adult mesenchymal stem cells for osteoarthritis
therapy
Ulrich Noth, Andre F Steinert and Rocky S Tuan
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhc0E4
----------------------
CASE STUDY
----------------------
Optic neuritis and recurrent myelitis in a woman with systemic lupus
erythematosus
Julius Birnbaum and Douglas Kerr
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhd0E5
----------------------
ARTICLE RESPONSES
----------------------
5-HT3 receptor antagonist for the treatment of tendinopathy
Kazem Mousavizadeh, Thomas Stratz, Wolfgang Mueller and Bernd L Fiebich
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhe0E6
Clinical studies can be performed in an ethical manner
Roy Fleischmann
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhf0E7
Author response to "Clinical studies can be performed in an ethical manner"
Paul L Romain
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Byhg0E8
=====================================================================
TOP TEN RHEUMATOLOGY ARTICLES
NEW! View the ten most popular articles from last month's issue of
Nature Clinical Practice Rheumatology.
Articles are ranked according to the number of times they have been
downloaded.
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0BkY40En
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/elvr0Xztnp0HjN0Zzu0E3
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
